Simple Breath Test to Examine Phenylalanine Metabolism
Use of a Simple Breath Test to Examine Phenylalanine Metabolism in Children With Phenylketonuria (PKU)
Sponsor: Rare Disease Foundation, Vancouver, Canada
This observational or N/A phase trial investigates Phenylketonuria (PKU) and is currently completed. Rare Disease Foundation, Vancouver, Canada leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Oct 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: EARLY_PHASE1 → None
-
Aug 2017 — Apr 2018 [monthly]
Completed EARLY_PHASE1
-
Feb 2017 — Aug 2017 [monthly]
Completed EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed Phase 0
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rare Disease Foundation, Vancouver, Canada
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .